XeriJect

2 stories · following the connections

Business

Xeris Pharmaceuticals Announces a Formulation Development Collaboration with Asahi Kasei Pharma

By Nasdaq OMXMar 13, 2018, 9:00 PM UTC

Business

Xeris Pharmaceuticals Announces New Results From Ready-To-Use Liquid Glucagon Clinical Development Program

By Nasdaq OMXJun 16, 2017, 11:51 AM UTC